comparemela.com

Latest Breaking News On - Lent asset management - Page 3 : comparemela.com

Bourne Lent Asset Management Inc Sells 1,600 Shares of The Procter & Gamble Company (NYSE:PG)

Bourne Lent Asset Management Inc Sells 1,600 Shares of The Procter & Gamble Company (NYSE:PG)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Adobe Inc (NASDAQ:ADBE) Shares Sold by Bourne Lent Asset Management Inc

Bourne Lent Asset Management Inc. lessened its holdings in Adobe Inc. (NASDAQ:ADBE – Free Report) by 1.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 71,329 shares of the software company’s stock after selling 900 shares during the […]

Bourne Lent Asset Management Inc Sells 900 Shares of Adobe Inc (NASDAQ:ADBE)

Bourne Lent Asset Management Inc. lessened its stake in shares of Adobe Inc. (NASDAQ:ADBE – Free Report) by 1.2% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 71,329 shares of the software company’s stock after selling 900 shares during the quarter. Adobe […]

Amgen Inc (NASDAQ:AMGN) Shares Sold by Bourne Lent Asset Management Inc

Bourne Lent Asset Management Inc. reduced its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,380 shares of the medical research company’s stock after selling 350 shares during the quarter. […]

Bristol-Myers Squibb (NYSE:BMY) Holdings Cut by Bourne Lent Asset Management Inc

Bourne Lent Asset Management Inc. lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.2% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 206,353 shares of the biopharmaceutical company’s stock after selling 4,700 shares during the period. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.